PROCESS FOR SYNTHESIS AND CRYSTALLINE FORM OF 4-{3-[CIS-HEXAHYDROCYCLOPENTA[C]PYRROL-2(1H)-YL]PROPOXY}BENZAMIDE HYDROCHLORIDE, IN ADDITION TO THE ASSOCIATED FREE BASE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
Industrial process for synthesis and crystalline form I of the compound of formula (I): and the crystalline form I of the associated free base. Medicaments.Procédé de synthèse industriel et forme cristalline I du composé de formule (I), ainsi que la forme cristalline I de la base libre associée. Médicaments.